Privileging Public Defense Research
In: Forthcoming in Mercer Law Review Vol. 69, No. 3, Spring 2018.
11770 results
Sort by:
In: Forthcoming in Mercer Law Review Vol. 69, No. 3, Spring 2018.
SSRN
In: http://hdl.handle.net/2027/uc1.b5072054
At top of title page: National Security Management. ; " . second of two texts prepared by the Industrial College to replace the textbook Research and Development, published in 1960"--Foreword. ; Bibliography: p. 183-189. ; Mode of access: Internet.
BASE
In: Revue française d'administration publique: publication trimestrielle, Issue 46, p. 59
ISSN: 0152-7401
World Affairs Online
In: Defense analysis, Volume 2, Issue 1, p. 51-53
ISSN: 1470-3602
This policy brief examines how innovation takes place within the Chinese defense research, development, and acquisition (RDA) system. This begins with a short review of the evolving frameworks of analysis of technological innovation in industrial systems, with prominence given to the coupled technology-push, market-pull model. Over the past 60 years, the Chinese defense RDA system has evolved from a top-down to a coupled model of interaction between weapons developers and military end-users. Important reforms have been taking place in the Chinese defense RDA system since the late 1990s, but serious structural impediments continue to exist that threatens to blunt the effectiveness of these improvements and keep the system in a trapped transition.
BASE
In: http://hdl.handle.net/2027/mdp.39015075642127
Shipping list no.: 2008-0382-P. ; "April 2008"--Preface. ; "DoDR&E(BR)." ; Cover title. ; Mode of access: Internet.
BASE
In: Public administration review: PAR, Volume 37, Issue 4, p. 347
ISSN: 1540-6210
In: Politics and the life sciences: PLS, Volume 9, Issue 1, p. 77
ISSN: 0730-9384
In: Politics and the life sciences: PLS ; a journal of political behavior, ethics, and policy, Volume 9, Issue 1, p. 77-84
ISSN: 1471-5457
The U.S. Army conducts the Biological Defense Research Program to provide medical protection for U.S. military personnel against the threat of biological weapons. The unclassified medical research program is consistent with the Biological Weapons Convention, which prohibits the production and stockpiling of biological and toxin weapons, and encourages the international exchange of scientific and medical information on the prevention and treatment of infectious diseases. The program is the source of secondary benefits to civilian public health in the form of vaccine and drug development, diagnostic capability, and contributions to the world body of knowledge on infectious diseases. As the executive agent for the program, the Army submits descriptions of the work conducted under the program to Congress as part of its budget request, and provides numerous other responses to Congressional scrutiny of the program. Internal monitoring of the program is conducted from the perspectives of safety, compliance with regulatory agencies, quality assurance, and close administrative and technical oversight of contracts.
In: Conference proceedings
In: Defence & peace economics, Volume 17, Issue 3, p. 165-167
ISSN: 1476-8267